General form of registration statement for all companies including face-amount certificate companies

Income Taxes - Net deffered tax assets (Details)

v3.21.2
Income Taxes - Net deffered tax assets (Details) - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Deferred tax assets:        
Deferred revenue   $ 200,000    
Total deferred tax assets $ 575,000 200,000    
Valuation allowance   (200,000)    
Evolv Technologies Holdings, Inc.        
Deferred tax assets:        
Net loss carryforwards   13,996,000 $ 10,404,000  
Research and development tax credit carryforwards   3,857,000 1,861,000  
Capitalized research and development costs   7,274,000 4,146,000  
Accrued expenses   334,000 56,000  
Deferred revenue   1,049,000 434,000  
Other   304,000 40,000  
Total deferred tax assets   26,814,000 16,941,000  
Valuation allowance   (26,005,000) (16,767,000) $ (12,157,000)
Total deferred tax assets, net of valuation allowance   809,000 174,000  
Deferred tax liabilities:        
Depreciation   (542,000) (174,000)  
Other   (267,000)    
Total deferred tax liabilities   (809,000) (174,000)  
Net deferred tax assets   $ 0 $ 0